Identification of two novel susceptibility genes to Takayasu Arteritis

July 8, 2013
(left)Fig. 1. Results of genome-scanning. X:Chromosomal position Y: Strength of association.(right)Fig. 2. Synergistic effect between IL12B and HLA-B*52:01.

Two novel susceptibility genes to Takayasu Arteritis have been identified by a research group from the Department of Rhematology and Clinical Immunology, Kyoto University Graduate School of Medicine. This study was published in American Journal of Human Genetics on July 4th, 2013.

Takayasu Arteritis (TAK) was reported for the first time by Japanese ophthalmologist, Prof. Migito Takayasu in 1908. TAK affects especially young women aged between 15 and 35. TAK is characterized by the involvement of large arteries especially the aorta and its large branches. Individuals with TAK develop a wide range of symptoms such as fatigue and lowering of vision in addition to its characteristic complications including aortic regurgitation (AR), pulseless and difference of blood pressure between right and left upper limbs (so it is also called 'pulseless disease'). Although corticosteroid and are often used for treatment of TAK, TAK often flares up during treatment.

Previous studies have revealed that are involved in the pathogenesis of TAK, and HLA-B*52:01 is so far the only established across the world.

The research group performed a genome-wide association (GWA) study of 167 TAK cases and 663 healthy controls and identified six candidates of susceptibility loci (Figure 1). We also performed a replication study consisting of 212 TAK cases and 1,322 controls. As a result, we found that the IL12B region (overallp=1.7x10-13) and the MLX region (overallp=5.2x10-7) as well as the HLA-B region (overallp=2.8x10-21) as susceptibility loci to TAK. IL12B encodes IL12p40 protein, a subunit of well-known inflammatory cytokine. MLX encodes a transcription factor whose significance is unknown. We also found a between the IL12B polymorphism and HLA-B*52:01. Those who were positive for both IL12B polymorphism and HLA-B*52:01 had odds ratio of 6.00 (95? confidence interval (CI):4.22-8.55), while those who were positive only for HLA-B*52:01 or the IL12B polymorphism showed OR of 1.80 (95?CI:1.11-2.93) or 1.74 (95?CI:1.23-2.47), respectively (Figure 2). In addition, we found that the IL12B polymorphism showed a significant association with clinical manifestations of TAK, including increased risk and severity of AR, a representative severe complication of TAK.

This is the first GWA study for TAK in the world. Low prevalence of this disease had made it difficult to collect DNA samples to obtain sufficient power to detect and perform a GWA study.

The associations between the IL12B polymorphism and clinical manifestations of TAK suggest the fundamental effects of IL12p40 protein on TAK progression as well as TAK onset. Previous studies have revealed that the IL12B region was associated with a wide variety of autoimmune disorders and infectious diseases, including psoriasis, inflammatory bowel diseases, and leprosy. Their findings indicate that common autoimmune mechanisms underlie the pathology of TAK and other autoimmune disorders such as psoriasis and inflammatory bowel diseases in which IL12B is involved as a genetic predisposing factor. Detection of these susceptibility loci will provide new insights to the basic mechanisms of TAK pathogenesis.

The research group is planning to analyze how IL12p40 exerts its effect on TAK pathology, using patients' samples. Further genetic analyses are under way to detect further susceptibility genes to TAK.

Explore further: Guatemala excavates early Mayan ruler's tomb

More information: Terao, C. et al. Two susceptibility loci to Takayasu arteritis reveal a synergistic role of the IL12B and HLA-B regions in a Japanese population, Am J Hum Genet, 2013.

Related Stories

Guatemala excavates early Mayan ruler's tomb

October 25, 2012
(AP)—Archaeologists announced Thursday they have uncovered the tomb of a very early Mayan ruler, complete with rich jade jewelry and decoration.

New drug improves glucose control without increasing risk of hypoglycemia in type 2 diabetes patients

February 26, 2012
TAK-875, a new treatment for type 2 diabetes, improves glycaemic (blood sugar) control and is equally as effective as the sulphonylurea glimepiride (a common drug treatment) but has a significantly lower risk of hypoglycaemia ...

Recommended for you

Scientists provide insight into genetic basis of neuropsychiatric disorders

July 21, 2017
A study by scientists at the Children's Medical Center Research Institute at UT Southwestern (CRI) is providing insight into the genetic basis of neuropsychiatric disorders. In this research, the first mouse model of a mutation ...

Scientists identify new way cells turn off genes

July 19, 2017
Cells have more than one trick up their sleeve for controlling certain genes that regulate fetal growth and development.

South Asian genomes could be boon for disease research, scientists say

July 18, 2017
The Indian subcontinent's massive population is nearing 1.5 billion according to recent accounts. But that population is far from monolithic; it's made up of nearly 5,000 well-defined sub-groups, making the region one of ...

Mutant yeast reveals details of the aberrant genomic machinery of children's high-grade gliomas

July 18, 2017
St. Jude Children's Research Hospital biologists have used engineered yeast cells to discover how a mutation that is frequently found in pediatric brain tumor high-grade glioma triggers a cascade of genomic malfunctions.

Late-breaking mutations may play an important role in autism

July 17, 2017
A study of nearly 6,000 families, combining three genetic sequencing technologies, finds that mutations that occur after conception play an important role in autism. A team led by investigators at Boston Children's Hospital ...

Newly identified genetic marker may help detect high-risk flu patients

July 17, 2017
Researchers have discovered an inherited genetic variation that may help identify patients at elevated risk for severe, potentially fatal influenza infections. The scientists have also linked the gene variant to a mechanism ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.